|

Ezabenlimab Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: BI 754091

Pipeline

Phase 1: 2

Top Sponsors

  • Johann Wolfgang Goethe University Hospital1
  • Boehringer Ingelheim1

Indications

  • Cancer2
  • Solid Tumors1
  • Glioblastoma1

Other1 trial

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
Phase 1

Los Angeles, California1 trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Valkyrie Clinical Trials

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.